/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
Company

FDA

Filtered to Funding & Financials ×
85 articles decelerating

In 2026, an FDA fast track for digital-health AI and Kintsugi’s clearance failure made the agency a central gatekeeper for healthcare software.

Who they are

FDA appears in this coverage as the U.S. regulator whose clearances, authorizations, trial approvals and enforcement role determine whether consumer devices, clinical software and brain-computer interfaces can move into healthcare use. Its recurring role is especially prominent around Apple, Samsung, Google, Neuralink and smaller digital-health developers.

The recent arc

Coverage intensified in the 2024 wearable-health cycle, led by Samsung’s authorization for Galaxy Watch sleep-apnea detection and the FDA’s approval of Apple’s sleep-apnea detection across recent Apple Watch models. Apple’s AirPods Pro 2 hearing-aid feature then became a landmark story: TechCrunch described it as the first over-the-counter hearing-aid software device.

The tension

The coverage circles a persistent trade-off between accelerating health-tech innovation and preserving a credible clinical gatekeeping function. Apple, Samsung and Google have sought regulatory validation for increasingly medical smartwatch features, while Neuralink and Paradromics depend on authorization to test brain implants; Kintsugi’s shutdown after failing to obtain clearance shows that the same threshold can constrain AI-health startups.

Why it matters

If the fast-track approach to digital health continues, FDA decisions could increasingly shape which AI tools become embedded in healthcare and consumer devices, not merely which conventional medical hardware reaches patients. The unresolved question in the coverage is whether quicker pathways can widen access without weakening the evidentiary standards that distinguish medical claims from general-purpose technology.

FDA has appeared in 85 articles since 2015-03. Coverage peaked in 2024Q2 with 7 articles. Frequently mentioned alongside Apple, the Apple Watch, The Food and Drug Administration, Neuralink.

Articles
85
mentions
Velocity
-25.0%
growth rate
Acceleration
-1.250
velocity change
Sources
34
publications
Robinhood’s $156M Boom Tests Prediction-Market Trust
Robinhood reported $156M in Q2 prediction-market revenue, more than 10 times its year-earlier total and ahead of stocks and crypto, as Kalshi’s disputes exposed...

Coverage Timeline

2025-07-31
Tech.eu 6 related

Oxford-based Ultromics, which has developed the first FDA-cleared, Medicare-reimbursed AI tools for cardiology diagnostics, raised a $55M Series C

The funding will accelerate Ultromics' mission to advance heart disease detection and scale EchoGo®, its AI platform for earlier, more accurate diagnoses.

2025-03-22
CNET 34 related

DoorDash partners with Klarna to offer payment plans, including credit options for purchases of $35 or more; Grubhub also uses Klarna as a payment option

in Case You Need a Loan to Pay for Your Burrito Jordan Valinsky / CNN : DoorDash will soon let users eat now and pay in installments Niket Nishant / Reuters : NYSE-bound Klarna signs payments deal wit...

2024-07-24
Bloomberg 1 related

LA-based Pearl, an FDA-approved startup that uses AI to assist dentists to make diagnoses, raised a $58M Series B led by Left Lane Capital at a $400M valuation

Katie Roof / Bloomberg :

2024-05-30
Tech.eu 3 related

Natural Cycles, an FDA-cleared birth control app with ~3M users, raised a $55M Series C led by Lauxera Capital Partners, bringing its total funding to $95M+

Cate Lawrence / Tech.eu :

2023-09-01
Fierce Biotech 2 related

Beta Bionics, which recently won FDA approval for its automated insulin dosing software, raised a $100M Series D, bringing its total funding to $293.5M

Andrea Park / Fierce Biotech :

2023-06-30
TechCrunch 4 related

Paris-based Gleamer, which develops AI software for radiologists, including its FDA-cleared BoneView, raised a €27M Series B, taking its total funding to €36M

Paul Sawers / TechCrunch :

2023-06-28
TechCrunch 10 related

Illinois-based Augmedics, which offers an FDA-approved AR system for spinal surgeries, raised an $82.5M Series D led by CPMG, taking its total funding to $148M

Ingrid Lunden / TechCrunch :

2023-05-19
CNBC 1 related

Austin-based brain-computer interface company Paradromics raised a $33M Series A and says it achieved an FDA designation that offers an expedited review process

Ashley Capoot / CNBC :

2022-06-17
Fierce Biotech 5 related

Aidoc, which develops AI-based tools for radiologists to analyze CT scans and X-rays, has raised a $110M Series D, bringing its total funding to about $250M

Aidoc is on quite the hot streak.  Aidoc is on quite the hot streak.  Just about two months after racking up its ninth FDA clearance …

2021-08-27
FierceBiotech 4 related

Overjet, which creates AI-based software for dental clinics, raises $27M Series A led by General Catalyst, Insight Partners; its tech recently got FDA clearance

After cutting its teeth automating the dental insurance claims process, Overjet is now ready to expand its artificial intelligence software …

Loading articles...

Quarterly Coverage

Top Sources

Narrative

TEXXR tracks 90 tech news articles mentioning FDA, dating back to March 2015. The biggest stories include Neuralink says the company received US FDA approval to launch its first-in-human clinical... and The US FDA clears hypertension notifications on Apple Watch, and Apple plans to roll out.... Frequently covered alongside Apple, The US FDA, the Apple Watch, Neuralink, and The Food and Drug Administration. Coverage has shifted toward safety, research themes and away from consumer, developer.

Key Moments

2024Q2developer -5pts; consumer +25pts; funding +20pts
2024Q3consumer -20pts; funding +20pts
2025Q2developer +13pts; consumer -80pts; funding -23pts

Relationships

Loading graph...